This expansion aims to further strengthen DMT’s presence within residential areas and enhance the delivery of tailored ...
Find Therapeutics secured CA$10 million in funding to continue advancing tasronetide, its treatment to restore damaged myelin ...
Toad venom (Chansu), first documented in the "Yaoxing Lun" (Treatise on the Properties of Medicines), is a treasured ...
Elon Musk’s company Neuralink has announced plans to expand its brain-computer interface (BCI) chip, The Link, to ...
PsyPost on MSN
Intranasal 5-MeO-DMT effects peak within 15 minutes and lack strong visuals, study finds
A study examining subjective experiences after intranasal application of 5-MeO-DMT found that its effects peak 8-15 minutes ...
Marc Dervaes journeyed to Mexico for a psychedelic drug that more military veterans are hoping will relieve their trauma.
A veteran of the Iraq and Afghanistan wars, Dervaes had one foot in the grave before contacting Ambio Life Sciences. Two ...
Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.
The method overcomes barriers of incomplete depolymerization and low product purity, promising a pathway toward true ...
From pricing and demand to regulation and risk, inside the business of psychedelic retreats catering to business leaders.
NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results